Marine Perrier

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Physical Activity

Sentinel Lymph Node

Ejection Fraction

Neuroendocrine Tumors

Top Venues

Journal of neuroendocrinology

Journal of the Endocrine Society

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Chevalier, Delphine Bonnet, Côme Lepage, Marine Perrier, Françoise Borson-Chazot, Juliette Abeillon, Jean Bernard Delobel, Arnaud Jannin, Julien Hadoux, Haissaguerre Magalie, Catherine Lombard-Bohas, Thomas Walter, Laurence Chardon
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group. Journal of the Endocrine Society 8 (7) (2024)
Benjamin Chevalier, Delphine Bonnet, Côme Lepage, Marine Perrier, Françoise Borson-Chazot, Juliette Abeillon, Jean Bernard Delobel, Arnaud Jannin, Julien Hadoux, Haissaguerre Magalie, Catherine Lombard-Bohas, Thomas Walter, Laurence Chardon
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group. Journal of the Endocrine Society 8 (7) (2024)
Benjamin Chevalier, Delphine Bonnet, Côme Lepage, Marine Perrier, Françoise Borson-Chazot, Juliette Abeillon, Jean Bernard Delobel, Arnaud Jannin, Julien Hadoux, Haissaguerre Magalie, Catherine Lombard-Bohas, Thomas Walter, Laurence Chardon
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group. Journal of the Endocrine Society 8 (7) (2024)
Benjamin Chevalier, Delphine Bonnet, Côme Lepage, Marine Perrier, Françoise Borson-Chazot, Juliette Abeillon, Jean Bernard Delobel, Arnaud Jannin, Julien Hadoux, Haissaguerre Magalie, Catherine Lombard-Bohas, Thomas Walter, Laurence Chardon
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group. Journal of the Endocrine Society 8 (7) (2024)
Caroline Lacombe, Marine Perrier, Olivia Hentic, Hedia Brixi, Ophélie De Rycke, Jérôme Cros, Vinciane Rebours, Guillaume Cadiot, Philippe Ruszniewski, Louis de Mestier
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of neuroendocrinology 35 (1) (2023)
Marine Perrier, Jean-Yves Scoazec, Thomas Walter
A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours. Therapeutic advances in medical oncology 15 (2023)
Caroline Lacombe, Marine Perrier, Olivia Hentic, Hedia Brixi, Ophélie De Rycke, Jérôme Cros, Vinciane Rebours, Guillaume Cadiot, Philippe Ruszniewski, Louis de Mestier
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of neuroendocrinology 35 (1) (2023)
Marine Perrier, Mathias Brugel, Laura Gérard, Bernard Goichot, Astrid Lièvre, Come Lepage, Vincent Hautefeuille, Christine Do Cao, Denis Smith, Philippe Thuillier, Jérôme Cros, Guillaume Cadiot, Thomas Walter, Louis de Mestier
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network. European journal of endocrinology (2023)
Caroline Lacombe, Marine Perrier, Olivia Hentic, Hedia Brixi, Ophélie De Rycke, Jérôme Cros, Vinciane Rebours, Guillaume Cadiot, Philippe Ruszniewski, Louis de Mestier
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of neuroendocrinology 35 (1) (2023)
Caroline Lacombe, Marine Perrier, Olivia Hentic, Hedia Brixi, Ophélie De Rycke, Jérôme Cros, Vinciane Rebours, Guillaume Cadiot, Philippe Ruszniewski, Louis de Mestier
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of neuroendocrinology 35 (1) (2023)
Lucie Duponchelle, Eric Baudin, Fabien Subtil, Christine Do Cao, Eric Dansin, Marine Perrier, Marie-Pierre Teissier, Magalie Haissaguerre, Xavier Cansouline, Julien Hadoux, Galina Jepiral, Catherine Lombard-Bohas, Olaf Mercier, François Tronc, Thomas Walter
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network. Journal of neuroendocrinology (2023)
Marine Perrier, Jean-Yves Scoazec, Thomas Walter
A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours. Therapeutic advances in medical oncology 15 (2023)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Amélie Lemoine, Marine Perrier, Camille Mazza, Anne Quinquenel, Mathilde Brasseur, Alain Jacques Delmer, Hervé Vallerand, Maxime Dewolf, Eric Bertin, Coralie Barbe, Damien Botsen, Olivier Bouche
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study. Cancers 14 (8) (2022)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Sophie Deguelte, Cheryne Hammoutene, Gilles Poncet, Laurent Brunaud, Marine Perrier, Reza Kianmanesh, Guillaume Cadiot
Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small-intestine neuroendocrine neoplasms: A multicentre preliminary study. Journal of neuroendocrinology 34 (6) (2022)
Marine Perrier, Stéphanie Polazzi, Annie Lemelin, Violaine Fernandez, Stéphanie Labonne, Delphine Maucort-Boulch, Catherine Lombard-Bohas, Antoine Duclos, Thomas Walter
Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study. Journal of neuroendocrinology 34 (4) (2022)
Pierre Martin, Damien Botsen, Mathias Brugel, Eric Bertin, Claire Carlier, Rachid Mahmoudi, Florian Slimano, Marine Perrier, Olivier Bouche
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Nutrients 14 (21) (2022)
Koceila Amroun, Raphael Chaltiel, Fabien Reyal, Reza Kianmanesh, Aude-Marie Savoye, Marine Perrier, Zoubir Djerada, Olivier Bouche
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels. Cancers 15 (1) (2022)
Caroline Lacombe, Marine Perrier, Olivia Hentic, Hedia Brixi, Ophélie De Rycke, Jérôme Cros, Vinciane Rebours, Guillaume Cadiot, Philippe Ruszniewski, Louis de Mestier
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of neuroendocrinology (2022)
Marine Perrier, Marie-Amelie Ordan, Coralie Barbe, Camille Mazza, Damien Botsen, Johanna Moreau, Yohann Renard, Mathilde Brasseur, Barbara Tailliere, Philippe Regnault, Eric Bertin, Olivier Bouche
Dynapenia in digestive cancer outpatients: association with markers of functional and nutritional status (the FIGHTDIGO study). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (1) (2021)
Sophie Deguelte, Marine Perrier, Cheryne Hammoutene, Guillaume Cadiot, Reza Kianmanesh
Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. Journal of clinical medicine 9 (7) (2020)